Pre-Eclampsia Pipeline Review and Therapeutic Development, H1 2015

Pre-Eclampsia - Pipeline Review, H1 2015 Report is now available at RnRMarketResearch store. This report provides comprehensive information on the therapeutic development for Pre-Eclampsia, complete with comparative analysis at various stages.

This report provides therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pre-Eclampsia and special features on late-stage and discontinued projects.

Get a copy of this report at . (This is a premium report price at US$2000 for a single user PDF license)


·         The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

·         The report reviews key players involved in the therapeutics development for Pre-Eclampsia and enlists all their major and minor projects

·         The report summarizes all the dormant and discontinued pipeline projects

·         The report provides a snapshot of the global therapeutic landscape of Pre-Eclampsia

·         A review of the Pre-Eclampsia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

·         A detailed assessment of monotherapy and combination therapy pipeline projects

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.